Priority Date: 27.01.12 (US 201261591297P)

INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1

  • Application ID: EP13701434
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). F. Hoffmann-La Roche AG is specialized in A61. F. Hoffmann-La Roche AG is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 27.01.2012 - Priority Date (US 201261591297P)
  • 01.08.2013 - Publication A1 (WO2013110679)
  • 03.12.2014 - Publication A1 (EP2806897)

IPC Classification